NCT07566429: A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)
- State
- Not started
- Phase
- Phase 2
- People
- 8 planned
- Started
- 25 Jan 2027
- Primary completion
- 15 Jun 2029
- Arms
- AB-1005 infusion
- Results
- None posted
- 5 May 2026: Trial registered